Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of colla
About this program
The Reissue of RFA-FD-23-001 grant supports clinical trials focused on orphan products, which are medical products developed for rare diseases. This initiative aims to encourage research and development in areas where there is a significant unmet medical need, providing funding to facilitate the clinical study of these products. The grant is intended for researchers and organizations engaged in the development of therapies for rare diseases, ensuring that innovative solutions can be explored and validated through rigorous clinical trials.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and for-profit entities involved in medical research and development.